1. Home
  2. BHK vs PHAR Comparison

BHK vs PHAR Comparison

Compare BHK & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Core Bond Trust

BHK

Blackrock Core Bond Trust

HOLD

Current Price

$8.89

Market Cap

668.8M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.18

Market Cap

925.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHK
PHAR
Founded
2001
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
668.8M
925.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BHK
PHAR
Price
$8.89
$13.18
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
348.9K
14.5K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
8.34%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
$8.74
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$8.69
$9.54
52 Week High
$10.12
$21.34

Technical Indicators

Market Signals
Indicator
BHK
PHAR
Relative Strength Index (RSI) 41.18 40.17
Support Level N/A $11.84
Resistance Level $9.07 $13.61
Average True Range (ATR) 0.08 0.45
MACD 0.01 0.07
Stochastic Oscillator 51.32 45.60

Price Performance

Historical Comparison
BHK
PHAR

About BHK Blackrock Core Bond Trust

Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: